Covalent Laboratories Private Limited Company Profile

17:25 EST 25th January 2015 | BioPortfolio

Covalent Laboratories Private Limited, an ISO 9001:2000 accredited pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins. It has a wide range of products and is fast expanding to meet the present and future market demands for the high value, low volume drugs. Covalent Laboratories manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities for both domestic and international markets. All the drugs manufactured meets USP/BP/JP standards


Flat No. 109, 1st Floor, Ram's Enclave, Erragadda
Andhra Pradesh


Phone: 91-40-23818102/03
Fax: 91-40-23815967

News Articles [752 Associated News Articles listed on BioPortfolio]

Dynamic covalent chemistry of bisimines at the solid/liquid interface monitored by scanning tunnelling microscopy

Constructing molecular architectures using dynamic covalent chemistry combines the robustness of covalent bonds with the reversibility of supramolecular chemistry. Now, a surface-mediated approach has...

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

Modifying or functionalizing transition metal dichalcogenides (TMDs) allows their properties to be altered and controlled. Now, non-defect-mediated covalent functionalization of single-layer semicondu...

Sagent Pharmaceuticals pays $85.3mm for Omega Laboratories

Sagent Pharmaceuticals Inc. (specialty injectables) acquired private Canadian company Omega Laboratories Ltd. for $85.3mm in cash.

Virtual Covalent Screening

Covalent drugs have been a big item in R&D over the last few years, and I wrote here about covalent fragments. The whole topic of reactive groups in small molecules and their interaction with living s...

Aginity and Covalent Marketing Present Webinar for Healthcare Marketers: Consumer-Centric Marketing – A Change Has Come

The Affordable Care Act has made customer insights more important than ever for healthcare payers. Aginity and Covalent Marketing are hosting a webinar to help

Principia Biopharma Successfully Completes Phase 1 Clinical Trial of PRN1008, a Novel Oral BTK Inhibitor for Autoimmune Diseases

Data support initiation of additional clinical trials in 2015 Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, today announced positive Phase 1 r...

Covalent docking of large libraries for the discovery of chemical probes

A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors

PubMed Articles [548 Associated PubMed Articles listed on BioPortfolio]

Reflections on public-private participation in healthcare.

Health care is one of the major issues in social policy, affected by multiple factors, such as the increase in health costs, crisis, and the degree of private participation in the financing of service...

Comparative performance of public and private sector delivery of BCG vaccination: Evidence from Sub-Saharan Africa.

The private sector is an important source of health care in the developing world. However, there is limited evidence on how private providers compare to public providers, particularly for preventive s...

Covalent Inhibition of New Delhi Metallo-β-Lactamase-1 (NDM-1) by Cefaclor.

Covalent irreversible inhibitors can successfully treat antibiotic-resistant infections by targeting serine β-lactamases. However, this strategy is useless for New Delhi metallo-β-lactamase (NDM), w...

Protocol for Rational Design of Covalently Interacting Inhibitors.

The inhibition potencies of covalent inhibitors mainly result from the formation of a covalent bond to the enzyme during the inhibition mechanism. This class of inhibitors has essentially been ignored...

ACO contracting with private and public payers: a baseline comparative analysis.

Objectives The accountable care organization (ACO) model is currently being pursued by private insurers, as well as federal and state governments. Little is known, however, about the prevalence of pri...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

B-Type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice

Cost-effective management of heart failure and pulmonary disease is of paramount importance. Unfortunately, the rapid and accurate differentiation of heart failure from other causes of dys...

Medical Education in a Private Hospital

The purpose of this study is to assess patient and companion acceptability of medical education in a non-teaching private hospital

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

To correlate the HLA type and genetic defect with hemophilia A.

A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

This one-arm, multi-centric, non-randomized, observational, open label, prospective study was designed to study short subjects born SGA, by pediatricians, endocrinologists or physicians in...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [1659 Associated Companies listed on BioPortfolio]

Covalent Laboratories Private Limited

Covalent Laboratories Private Limited, an ISO 9001:2000 accredited pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins. It has a wi...

Convalent group

A leader in the design, development, and management of complex clinical trials for the world's leading pharmaceutical, biotechnology, and medical device companies, Covalent Group's intellectual, hard ...

Covalent Marketing

Covalent Group Incorporated

The Covalent Group is a unique drug development and research managment company with the ability to design complete development strategies, provide input from world-renown thought leaders, design and a...

EIC Laboratories, Inc

EIC Laboratories is a research and development corporation serving government and industrial clients worldwide. Since our inception in 1971, EIC Laboratories has been committed to converting basic res...

More Information about "Covalent Laboratories Private Limited" on BioPortfolio

We have published hundreds of Covalent Laboratories Private Limited news stories on BioPortfolio along with dozens of Covalent Laboratories Private Limited Clinical Trials and PubMed Articles about Covalent Laboratories Private Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Covalent Laboratories Private Limited Companies in our database. You can also find out about relevant Covalent Laboratories Private Limited Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record